{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:58:43Z","timestamp":1781038723775,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["302060\/2029-7"],"award-info":[{"award-number":["302060\/2029-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["303782\/2024-2"],"award-info":[{"award-number":["303782\/2024-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["465539\/2014-9"],"award-info":[{"award-number":["465539\/2014-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.humimm.2026.111725","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:44:35Z","timestamp":1775522675000},"page":"111725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone marrow and peripheral blood HLA-G in hematologic diseases presenting with impaired erythropoiesis: HLA-G in disorders with impaired erythropoiesis"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8274-3576","authenticated-orcid":false,"given":"Bruna","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Lobo de","family":"Figueriedo-Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3111-8506","authenticated-orcid":false,"given":"Priscila Santos","family":"Scheucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Tocantins","family":"Calado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Traina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9457-9601","authenticated-orcid":false,"given":"Eduardo Antonio","family":"Donadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2026.111725_b0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00018-010-0580-7","article-title":"Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association","volume":"68","author":"Donadi","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.humimm.2026.111725_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/734068","article-title":"Transcriptional and posttranscriptional regulations of the HLA-G gene","volume":"2014","author":"Castelli","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2026.111725_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169032","article-title":"Haplotypes of the HLA-G 3' Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell lines Differentially","volume":"12","author":"Poras","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2026.111725_b0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00018-010-0579-0","article-title":"The role of HLA-G in immunity and hematopoiesis","volume":"68","author":"Carosella","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.humimm.2026.111725_b0025","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1182\/blood-2004-03-0809","article-title":"Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis","volume":"104","author":"Menier","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111725_b0030","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood.2021011045","article-title":"Ineffective erythropoiesis and its treatment","volume":"139","author":"Cazzola","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111725_b0035","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2022.14578","article-title":"Diagnosis and Treatment of Myelodysplastic Syndromes: a Review","volume":"328","author":"Sekeres","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.humimm.2026.111725_b0040","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1056\/NEJMra1406186","article-title":"Myeloproliferative Neoplasms","volume":"376","author":"Spivak Jerry","year":"2017","journal-title":"New England J. Med."},{"key":"10.1016\/j.humimm.2026.111725_b0045","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/ajh.27002","article-title":"Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.humimm.2026.111725_b0050","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ajh.26920","article-title":"JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management","volume":"98","author":"Gangat","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.humimm.2026.111725_b0055","doi-asserted-by":"crossref","DOI":"10.1080\/17474086.2023.2192475","article-title":"Secondary Erythrocytosis","volume":"16","author":"Babakhanlou","year":"2023","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.humimm.2026.111725_b0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12185-024-03715-1","article-title":"Aplastic anemia: history and recent developments in diagnosis and treatment","volume":"119","author":"Onishi","year":"2024","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.humimm.2026.111725_b0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/j.seminhematol.2021.12.002","article-title":"Aplastic anemia: Pathophysiology","volume":"59","author":"Giudice","year":"2022","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.humimm.2026.111725_b0070","first-page":"33","article-title":"E. D. Carosella, N. Rouas-Freiss, D. Tronik-Le Roux, P. Moreau, J. LeMaoult, HLA-G","volume":"127","author":"Molecule","year":"2015","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.humimm.2026.111725_b0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cyto.2017.07.014","article-title":"Cytokines and soluble HLA-G levels in bone marrow stroma and their association with the survival rate of patients exhibiting childhood T-cell acute lymphoblastic leukemia","volume":"102","author":"Almeida","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.humimm.2026.111725_b0080","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ajh.26984","article-title":"Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Garcia-Manero","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.humimm.2026.111725_b0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41408-025-01235-7","article-title":"Evolution of WHO diagnostic criteria in \u201cClassical Myeloproliferative Neoplasms\u201d compared with the International Consensus Classification","volume":"15","author":"Thiele","year":"2025","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.humimm.2026.111725_b0090","doi-asserted-by":"crossref","unstructured":"H.-Y. Kim, H.-J. Kim, S.-H. Kim, Genetics and genomics of bone marrow failure syndrome, 57 (2022) 86\u201392.","DOI":"10.5045\/br.2022.2022056"},{"key":"10.1016\/j.humimm.2026.111725_b0095","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2026.111725_b0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MOH.0000000000000328","article-title":"Characterization, regulation, and targeting of erythroid progenitors in normal and disordered human erythropoiesis","volume":"24","author":"Dulmovits","year":"2017","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.humimm.2026.111725_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.112684","article-title":"Immunophenotypic dissection of normal hematopoiesis","volume":"475","author":"Orfao","year":"2019","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.humimm.2026.111725_b0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cyto.b.22046","article-title":"Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet","volume":"104","author":"van der Velden","year":"2023","journal-title":"Cytometry B Clin. Cytom."},{"issue":"578","key":"10.1016\/j.humimm.2026.111725_b0115","first-page":"e571","article-title":"Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in older adults with Acute Myeloid Leukemia","volume":"29","author":"Abid","year":"2023","journal-title":"Transplantation and Cellular Therapy"},{"key":"10.1016\/j.humimm.2026.111725_b0120","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00018-022-04359-2","article-title":"The HLA-G immune checkpoint: a new immuno-stimulatory role for the \u03b11-domain-deleted isoform","volume":"79","author":"Tronik-Le Roux","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.humimm.2026.111725_b0125","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13585","article-title":"Plasma levels of soluble HLA-G and cytokines in papillary thyroid carcinoma before and after thyroidectomy","volume":"74","author":"Bertol","year":"2020","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.humimm.2026.111725_b0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-0039.2009.01302.x","article-title":"Characterization of HLA-G expression in renal cell carcinoma","volume":"74","author":"Li","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2026.111725_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100590","article-title":"Update on mutations in the HIF: EPO pathway and their role in erythrocytosis","volume":"37","author":"Lappin","year":"2019","journal-title":"Blood Rev."},{"key":"10.1016\/j.humimm.2026.111725_b0140","doi-asserted-by":"crossref","first-page":"63690","DOI":"10.18632\/oncotarget.11628","article-title":"Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2","volume":"7","author":"Yaghi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2026.111725_b0145","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/sj.leu.2405050","article-title":"HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera","volume":"22","author":"Menier","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.humimm.2026.111725_b0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0198-8859(02)00821-2","article-title":"Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules","volume":"64","author":"Menier","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2026.111725_b0155","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1038\/s41598-018-24009-7","article-title":"The genetic diversity within the 1.4\u2009kb HLA-G 5' upstream regulatory region moderately impacts on cellular microenvironment responses","volume":"8","author":"Dias","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2026.111725_b0160","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.humimm.2010.08.011","article-title":"Increased soluble human leukocyte antigen\u2013G levels in peripheral blood from climbers on Mount Everest","volume":"71","author":"Bourguignon","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2026.111725_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071742","article-title":"Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population","volume":"8","author":"Martelli-Palomino","year":"2013","journal-title":"PLoS One"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:25:27Z","timestamp":1781036727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926000716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0198885926000716"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111725","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow and peripheral blood HLA-G in hematologic diseases presenting with impaired erythropoiesis: HLA-G in disorders with impaired erythropoiesis","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}],"article-number":"111725"}}